New vaccines developed for adults will help eradicate Tuberculosis faster, claim researchers.
Scientists at the London School of Hygiene and Tropical Medicine and the Stop TB Department at the World Health Organization found that a vaccine given to adolescents and adults in low- and middle-income countries could have a much larger impact on the burden of TB worldwide and is more likely to be cost-effective, even if the vaccine has low efficacy and short duration or carries a high price.
Vaccination of TB in adults and adolescents is much more impactful than providing vaccine for children. In low- and middle-income countries would have a much larger benefit from this worldwide and it is likely to be cost-effective, even with low efficacy and short duration or carries a high price.
TB mostly affects young adults and kills more than one million people every year, 95% of whom are in low- and middle-income countries. The World Health Organization has set the goal of eliminating TB by the year 2050.
The research was published in 'Proceedings of the National Academy of Sciences.'